Active Ingredient(s): Canakinumab
FDA Approved: * June 17, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Anti-Inflammatory

Canakinumab (INN), sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis (SJIA) and active Still's disease, including adult-onset Still's disease (AOSD).[2][3] It is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.[4] Common side effects include infections (colds and upper re... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Ilaris 150 mg/ml Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 0078-0582
Novartis Pharmaceuticals Corporation
Ilaris 150 mg/ml Subcutaneous Injection, Solution
NDC: 0078-0734
Novartis Pharmaceuticals Corporation

Popular Topics


How old is this product...

le cout d Ilaris

je dois commencer ce med. mais il est trop cher . comment faire ? je soufre bcq. j ai de la fievre familliale qui me cau...

how good is the new medicine Ilaris

Its is the recent new of the product Ilaris has got a US FDA approval and has been there across various territories. Doe...